References
1. Fried L.P., Tangen C.M., Walston J., et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001; 56: M146–56.
2. Fried L.P., Ferrucci L., Darer J., Williamson J.D., Anderson G. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci. 2004; 59: 255–63.
3. Hoogendijk E.O., Afilalo J., Ensrud K.E., Kowal P., Onder G., Fried L.P. Frailty: implications for clinical practice and public health. Lancet. 2019; 394: 1365–75.
4. Clegg A., Young J., Iliffe S., Rikkert M.O., Rockwood K. Frailty in elderly people. Lancet. 2013; 381: 752–62.
5. Khan H., Kalogeropoulos A.P., Georgiopoulou V.V., et al. Frailty and risk for heart failure in older adults: the Health, Aging, and Body Composition Study. Am Heart J. 2013; 166: 887–94.
6. Denfeld Q.E., Winters-Stone K., Mudd J.O., Gelow J.M., Kurdi S., Lee C.S. The prevalence of frailty in heart failure: a systematic review and meta-analysis. Int J Cardiol. 2017; 236: 283–9.
7. Bielecka-Dabrowa A., Ebner N., dos Santos M.R., Ishida J., Hasenfuss G, von Haehling S. Cachexia, muscle wasting, and frailty in cardiovascular disease. Eur J Heart Fail. 2020; 22: 2314–26.
8. Vitale C., Jankowska E., Hill L., et al. Heart Failure Association/European Society of Cardiology position paper on frailty in patients with heart failure. Eur J Heart Fail. 2019; 21: 1299–305.
9. Upadhya B., Pisani B., Kitzman D.W. Evolution of a geriatric syndrome: pathophysiology and treatment of heart failure with preserved ejection fraction. J Am Geriatr Soc. 2017; 65: 2431–40.
10. Dewan P., Jackson A., Jhund P.S., et al. The prevalence and importance of frailty in heart failure with reduced ejection fraction-an analysis of PARADIGM-HF and ATMOSPHERE. Eur J Heart Fail. 2020; 22: 2123–33.
11. Sanders N.A., Supiano M.A., Lewis E.F., et al. The frailty syndrome and outcomes in the TOPCAT trial. Eur J Heart Fail. 2018; 20: 1570–7.
12. Zhang Y., Yuan M., Gong M., Tse G., Li G., Liu T. Frailty and clinical outcomes in heart failure: a systematic review and meta-analysis. J Am Med Dir Assoc. 2018; 19:1003–8.e1.
13. Bottle A., Kim D., Hayhoe B., et al. Frailty and comorbidity predict first hospitalisation after heart failure diagnosis in primary care: population-based observational study in England. Age Ageing. 2019; 48: 347–54.
14. Vidán M.T., Blaya-Novakova V., Sanchez E., Ortiz J., Serra-Rexach J.A., Bueno H. Prevalence and prognostic impact of frailty and its components in non-dependent elderly patients with heart failure. Eur J Heart Fail. 2016; 18: 869–75.
15. Greene S.J., Butler J., Albert N.M., et al. Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF Registry. J Am Coll Cardiol. 2018; 72: 351–66.
16. Brunner-La Rocca H.-P., Linssen G.C., Smeele F.J., et al. Contemporary drug treatment of chronic heart failure with reduced ejection fraction: the CHECK-HF Registry. JACC Heart Fail. 2019; 7: 13–21.
17. Veenis J.F., Brunner-La Rocca H.P., Linssen G.C.M., et al. Age differences in contemporary treatment of patients with chronic heart failure and reduced ejection fraction. Eur J Prev Cardiol. 2019; 26: 1399–407.
18. Curtin D., Dukelow T., James K., O’Donnell D., O’Mahony D., Gallagher P. Deprescribing in multimorbid older people with polypharmacy: agreement between STOPPFrail explicit criteria and gold standard deprescribing using 100 standardized clinical cases. Eur J Clin Pharmacol. 2019; 75: 427–32.
19. Kubala M., Guédon-Moreau L., Anselme F., et al. Utility of frailty assessment for elderly patients undergoing cardiac resynchronization therapy. JACC Clin Electrophysiol. 2017; 3: 1523–33.
20. Pulignano G., Del Sindaco D., Di Lenarda A., et al. Usefulness of frailty profile for targeting older heart failure patients in disease management programs: a cost-effectiveness, pilot study. J Cardiovasc Med. 2010; 11: 739–47.
21. Solomon S.D., McMurray J.J.V., Anand I.S., et al. Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction. N Engl J Med. 2019; 381: 1609–20.
22. Mitnitski A.B., Mogilner A.J., Rockwood K. Accumulation of deficits as a proxy measure of aging. Sci World J. 2001; 1: 323–36.
23. Rockwood K., Mitnitski A. Frailty in relation to the accumulation of deficits. J Gerontol A Biol Sci Med Sci. 2007; 62: 722–7.
24. Searle S.D., Mitnitski A., Gahbauer E.A., Gill T.M., Rockwood K. A standard procedure for creating a frailty index. BMC Geriatr. 2008; 8: 24.